CD274 and small cell lung carcinoma: Given this heterogeneity of results in the literature, Acheampong and colleagues performed a meta-analysis of PD-L1 expression that covered 2792 patients and displayed an estimated pooled prevalence of PD-L1 expression in cases of SCLC to be 26% with an interstudy range of PD-L1 expression of 83%.